dronabinol has been researched along with clomipramine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (53.85) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fennessy, MR; Taylor, DA | 3 |
| Schoenfeld, RI | 1 |
| Fennessy, MR; Taylor, DA; Verberne, AJ | 2 |
| Davies, JA; Graham, JD | 1 |
1 review(s) available for dronabinol and clomipramine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for dronabinol and clomipramine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
"Antagonist"-precipitated withdrawal in the rat after chronic delta9-tetrahydrocannabinol treatment.
Topics: Animals; Behavior, Animal; Body Temperature; Clomipramine; Dibenzazepines; Dronabinol; Feeding Behavior; Humans; Male; Rats; Substance Withdrawal Syndrome; Time Factors | 1978 |
Antagonism of the effects on thermoregulation of delta9-tetrahydrocannabinol by clomipramine in the rat.
Topics: Animals; Biogenic Amines; Body Temperature Regulation; Brain Chemistry; Clomipramine; Dibenzazepines; Dronabinol; Male; Motor Activity; Rats | 1978 |
Lysergic acid diethylamide- and mescaline-induced attenuation of the effect of punishment in the rat.
Topics: Amides; Animals; Behavior, Animal; Brain Stem; Clomipramine; Cyproheptadine; Dronabinol; Electroshock; Lysergic Acid Diethylamide; Male; Mescaline; N,N-Dimethyltryptamine; Neurons; Punishment; Rats; Receptors, Drug; Serotonin | 1976 |
Time-course of the effects of chronic delta 9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behaviour in the rat.
Topics: Animals; Behavior, Animal; Biogenic Amines; Body Temperature; Brain Chemistry; Clomipramine; Dronabinol; Humans; Male; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Time Factors | 1982 |
Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol.
Topics: Animals; Biogenic Amines; Body Weight; Clomipramine; Dronabinol; Eating; Fluoxetine; Humans; Imipramine; Male; Rats; Substance Withdrawal Syndrome; Time Factors | 1980 |
The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice.
Topics: Animals; Biogenic Amines; Body Temperature; Clomipramine; Dronabinol; Fenclonine; Haloperidol; Male; Methysergide; Mice; Phenoxybenzamine | 1980 |
Attenuation of delta 9-tetrahydrocannabinol-induced withdrawal-like behaviour by delta 9-tetrahydrocannabinol.
Topics: Animals; Behavior, Animal; Clomipramine; Dronabinol; Humans; Male; Rats; Substance Withdrawal Syndrome | 1981 |